Replies to post #221839 on Biotech Values

[rfj1862]

MRKR's technology looks great.

The problem, of course, is that if you're treating a relatively rare disease with a therapy that is that inexpensive you're not going to be making all that much money.

This does seem worthy of further investigation though.

[rkrw]

Looks like Baker has $5.4m into it which is a rounding error. Headline is very misleading at least with respect to them.